Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Campbell, Patricia ^a   McIntyre, Peter ^b   Quinn, Helen ^b   Hueston, Linda ^c   Gilbert, Gwendolyn L ^c   McVernon, Jodie ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TOXIN ANTIBODY; ACELLULAR VACCINE; BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; PERTUSSIS TOXIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUSTRALIA; CHILD; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE SURVEILLANCE; HUMAN; PERTUSSIS; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; AGED; BLOOD; BORDETELLA PERTUSSIS; EPIDEMIC; EPIDEMIOLOGY; FEMALE; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PATHOGENICITY; PREVALENCE; SEROTYPING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; AUSTRALIA; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; EPIDEMICS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; PERTUSSIS TOXIN; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SEROTYPING; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 84860480152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035874     Document Type: Article

References (33)

1. Crowcroft NS, Pebody RG, (2006) Recent developments in pertussis. Lancet 367: 1926-1936.
2. World Health Organization (2010) Immunization, Vaccines and Biologicals. Pertussis. Available: http://www.who.int/immunization/topics/pertussis/en/index.html#. Accessed 2011 Jan 24.
3. Guiso N, Wirsing Von König CH, Forsyth K, Tan T, Plotkin SA, (2011) The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine 29: 1115-1121 doi:10.1016/j.vaccine.2010.12.010.
4. Cagney M, MacIntyre CR, McIntyre P, Puech M, Giammanco A, (2006) The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiol Infect 134: 1208-1216.
5. Andrews R, Herceg A, Roberts C, (1997) Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell 21: 145-148.
6. Quinn HE, McIntyre PB, (2011) The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia. Bull World Health Organ 89: 666-674 doi:10.2471/BLT.11.086538.
7. Quinn HE, McIntyre PB, Backhouse JL, Gidding HF, Brotherton J, et al. (2010) The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiol Infect 138: 426-433.
8. Hull B, Deeks S, Menzies R, McIntyre P, (2009) Immunisation coverage annual report, 2007. Commun Dis Intell 33: 170-187.
9. McIntyre P, (2003) Lessons from surveillance: solving the pertussis puzzle. NSW Public Health Bull 14: 69-71.
10. Quinn HE, McIntyre PB, (2007) Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Commun Dis Intell 31: 205-215.
11. Australian Government Department of Health and Ageing (2011) National Notifiable Diseases Surveillance System. Available: http://www9.health.gov.au/cda/source/cda-index.cfm. Accessed 2012 Jan 17.
12. Spokes PJ, Quinn HE, McAnulty JM, (2010) Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. NSW Public Health Bull 21: 167-173 doi:10.1071/NB10031.
13. de Melker HE, Versteegh FGA, Conyn-van Spaendonck MAE, Elvers LH, Berbers GAM, et al. (2000) Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 38: 800-806.
14. Nardone A, Pebody RG, Maple PAC, Andrews N, Gay NJ, et al. (2004) Sero-epidemiology of Bordetella pertussis in England and Wales. Epidemiol Infect 22: 1314-1319 doi:10.1016/j.vaccine.2003.08.039.
15. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, et al. (2005) The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133: 159-171.
16. Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, et al. (2010) The seroepidemiology of Bordetella pertussis in Israel-Estimate of incidence of infection. Vaccine 28: 3285-3290 doi:10.1016/j.vaccine.2010.02.104.
17. Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL, (2002) A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 20: 3130-3136.
18. Giammanco A, Taormina S, Chiarini A, Dardanoni G, Stefanelli P, et al. (2003) Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. Vaccine 21: 1924-1931 doi:10.1016/S0264-410X(02)00823-X.
19. Australian Government Department of Health and Ageing (2004) Australian national notifiable diseases case definitions: Pertussis case definition. Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_pertus.htm. Accessed 2012 Jan 11.
20. Rushworth R, Bell S, Rubin G, Hunter R, Ferson M, (1991) Improving surveillance of infectious diseases in New South Wales. Med J Aust 154: 828-831.
21. Australian Bureau of Statistics (2011) Australian demographic statistics, Table 59. Estimated resident population by single year of age, Australia, time series spreadsheet, cat. no 3101.0. Available: http://www.abs.gov.au/ausstats/abs.nsf/mf/3101.0. Accessed 2012 Jan 17.
22. Hueston L, Lanser J, Gidding H, Gilbert L, (2007) Communicable diseases report, NSW, January and February 2007: False positive pertussis serological tests. NSW Public Health Bull 18: 67-68.
23. Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, et al. (1998) Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 132: 983-988.
24. Hallander HO, Gustafsson L, Ljungman M, Storsaeter J, (2005) Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 23: 5359-5364 doi:10.1016/j.vaccine.2005.06.009.
25. Torvaldsen S, McIntyre PB, (2003) Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatr Infect Dis J 22: 956-959.
26. Ramsay M, Farrington C, Miller E, (1993) Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 111: 41-48.
27. Lavine JS, King AA, Bjørnstad ON, (2011) Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci USA 108: 7259-7264 doi:10.1073/pnas.1014394108.
28. de Melker HE, Versteegh FGA, Schellekens JFP, Teunis PFM, Kretzschmar M, (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53: 106-113 doi:10.1016/j.jinf.2005.10.020.
29. de Greeff SC, de Melker HE, van Gageldonk PGM, Schellekens JFP, van der Klis FRM, et al. (2010) Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PloS ONE 5: e14183 doi:10.1371/journal.pone.0014183.
30. Kretzschmar M, Teunis PFM, Pebody RG, (2010) Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 7: e1000291 doi:10.1371/journal.pmed.1000291.
31. Wang C-Q, Zhu Q-R, (2011) Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Pediatr Infect Dis J 30: 1-4 doi:10.1097/INF.0b013e31820eaf88.
32. Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E, (2009) Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS 117: 912-922 doi:10.1111/j.1600-0463.2009.02554.x.
33. Storsaeter J, Hallander HO, Gustafsson L, Olin P, (2003) Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21: 3542-3549 doi:10.1016/S0264-410X(03)00407-9.